{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["bioavailability", "in-vitro", "in-vivo study", "microfluidic technology", "rats", "repaglinide (Rp)"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37189682", "DateRevised": {"Year": "2023", "Month": "05", "Day": "19"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "04", "Day": "01"}], "Language": ["eng"], "ELocationID": ["1064", "10.3390/biomedicines11041064"], "Journal": {"ISSN": "2227-9059", "JournalIssue": {"Volume": "11", "Issue": "4", "PubDate": {"Year": "2023", "Month": "Apr", "Day": "01"}}, "Title": "Biomedicines", "ISOAbbreviation": "Biomedicines"}, "ArticleTitle": "Formulation and Optimization of Repaglinide Nanoparticles Using Microfluidics for Enhanced Bioavailability and Management of Diabetes.", "Abstract": {"AbstractText": ["The technologies for fabrication of nanocrystals have an immense potential to improve solubility of a variety of the poor water-soluble drugs with subsequent enhanced bioavailability. Repaglinide (Rp) is an antihyperglycemic drug having low bioavailability due to its extensive first-pass metabolism. Microfluidics is a cutting-edge technique that provides a new approach for producing nanoparticles (NPs) with controlled properties for a variety of applications. The current study's goal was to engineer repaglinide smart nanoparticles (Rp-Nc) utilizing microfluidic technology (Dolomite Y shape), and then to perform in-vitro, in-vivo, and toxicity evaluations of them. This method effectively generated nanocrystals with average particle sizes of 71.31 \u00b1 11 nm and a polydispersity index (PDI) of 0.072 \u00b1 12. The fabricated Rp's crystallinity was verified by Differential scanning calorimetry (DSC) and Powder X-ray diffraction (PXRD). In comparison to the raw and commercially available tablets, the fabricated Rp's nanoparticles resulted in a higher saturation solubility and dissolving rate (<i>p</i> < 0.05). Rp nanocrystals had a considerably lower (<i>p</i> < 0.05) IC<sub>50</sub> value than that of the raw drug and commercial tablets. Moreover, Rp nanocrystals at the 0.5 and 1 mg/kg demonstrated a significant decrease in blood glucose level (mg/dL, <i>p</i> < 0.001, <i>n</i> = 8) compared to its counterparts. Rp nanocrystals at the 0.5 mg/kg demonstrated a significant decrease (<i>p</i> < 0.001, <i>n</i> = 8) in blood glucose compared to its counterparts at a dose of 1 mg/kg. The selected animal model's histological analyses and the effect of Rp nanocrystals on several internal organs were determined to be equivalent to those of the control animal group. The findings of the present study indicated that nanocrystals of Rp with improved anti-diabetic properties and safety profiles can be successfully produced using controlled microfluidic technology, an innovative drug delivery system (DDS) approach."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, University of Malakand, Chakdara 18800, Pakistan."}], "LastName": "Ahmad", "ForeName": "Mubashir", "Initials": "M"}, {"Identifier": ["0000-0002-3464-5435"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center for Pharmaceutical Engineering Science, Faculty of Life Sciences, School of Pharmacy and Medical Sciences, University of Bradford, Bradford BD7 1DP, UK."}], "LastName": "Khan", "ForeName": "Shahzeb", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Sarhad University of Science and Information Technology, Peshawar 18500, Pakistan."}], "LastName": "Shah", "ForeName": "Syed Muhammad Hassan", "Initials": "SMH"}, {"Identifier": ["0000-0002-4528-8517"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, University of Malakand, Chakdara 18800, Pakistan."}], "LastName": "Zahoor", "ForeName": "Muhammad", "Initials": "M"}, {"Identifier": ["0000-0002-6978-3133"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutics and Pharmaceutical Technology, College of Pharmacy, University of Sharjah, Sharjah 27272, United Arab Emirates."}, {"Identifier": [], "Affiliation": "Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah 27272, United Arab Emirates."}], "LastName": "Hussain", "ForeName": "Zahid", "Initials": "Z"}, {"Identifier": ["0000-0001-6121-5441"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Shaheed Benazir Bhutto University, Sheringal Dir 18000, Pakistan."}], "LastName": "Hussain", "ForeName": "Haya", "Initials": "H"}, {"Identifier": ["0000-0001-8143-2363"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, University of Malakand, Chakdara 18800, Pakistan."}], "LastName": "Shah", "ForeName": "Syed Wadood Ali", "Initials": "SWA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Aromatic and Poisonous Plants Research Center, Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia."}], "LastName": "Ullah", "ForeName": "Riaz", "Initials": "R"}, {"Identifier": ["0000-0001-9819-447X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Basic Science, College of Medicine, Princess Nourah bint Abdulrahman University, Riyadh 11671, Saudi Arabia."}], "LastName": "Alotaibi", "ForeName": "Amal", "Initials": "A"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Biomedicines", "NlmUniqueID": "101691304", "ISSNLinking": "2227-9059"}, "CoiStatement": "The authors of this article have no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "R\u00edos J.L., Francini F., Schinella G.R. Natural products for the treatment of type 2 diabetes mellitus. Planta Med. 2015;81:975\u2013994. doi: 10.1055/s-0035-1546131.", "ArticleIdList": ["10.1055/s-0035-1546131", "26132858"]}, {"Citation": "Patle D., Vyas M., Khatik G.L. A review on natural products and herbs used in the management of diabetes. Curr. Diabetes Rev. 2021;17:186\u2013197.", "ArticleIdList": ["32268866"]}, {"Citation": "Patterson C.C., Karuranga S., Salpea P., Saeedi P., Dahlquist G., Soltesz G., Ogle G.D. Worldwide estimates of incidence, prevalence and mortality of type 1 diabetes in children and adolescents: Results from the International Diabetes Federation Diabetes Atlas. Diabetes Res. Clin. Pract. 2019;157:107842. doi: 10.1016/j.diabres.2019.107842.", "ArticleIdList": ["10.1016/j.diabres.2019.107842", "31518658"]}, {"Citation": "Huang Y.-C., Chen B.-H. A Comparative Study on Improving Streptozotocin-Induced Type 2 Diabetes in Rats by Hydrosol, Extract and Nanoemulsion Prepared from Cinnamon Leaves. Antioxidants. 2022;12:29. doi: 10.3390/antiox12010029.", "ArticleIdList": ["10.3390/antiox12010029", "PMC9855112", "36670891"]}, {"Citation": "Yeung A.W.K., Tzvetkov N.T., Durazzo A., Lucarini M., Souto E.B., Santini A., Gan R.-Y., Jozwik A., Grzybek W., Horba\u0144czuk J.O. Natural products in diabetes research: Quantitative literature analysis. Nat. Prod. Res. 2021;35:5813\u20135827. doi: 10.1080/14786419.2020.1821019.", "ArticleIdList": ["10.1080/14786419.2020.1821019", "33025819"]}, {"Citation": "Rahman M.M., Islam M.R., Shohag S., Hossain M.E., Rahaman M.S., Islam F., Ahmed M., Mitra S., Khandaker M.U., Idris A.M. The multifunctional role of herbal products in the management of diabetes and obesity: A comprehensive review. Molecules. 2022;27:1713. doi: 10.3390/molecules27051713.", "ArticleIdList": ["10.3390/molecules27051713", "PMC8911649", "35268815"]}, {"Citation": "Viv\u00f3-Barrachina L., Rojas-Chac\u00f3n M.J., Navarro-Salazar R., Belda-Sanchis V., P\u00e9rez-Murillo J., Peir\u00f3-Puig A., Herran-Gonz\u00e1lez M., P\u00e9rez-Bermejo M. The Role of Natural Products on Diabetes Mellitus Treatment: A Systematic Review of Randomized Controlled Trials. Pharmaceutics. 2022;14:101. doi: 10.3390/pharmaceutics14010101.", "ArticleIdList": ["10.3390/pharmaceutics14010101", "PMC8782046", "35056997"]}, {"Citation": "Van Heiningen P., Hatorp V., Kramer Nielsen K., Hansen K., Van Lier J., De Merbel N., Oosterhuis B., Jonkman J. Absorption, metabolism and excretion of a single oral dose of 14C-repaglinide during repaglinide multiple dosing. Eur. J. Clin. Pharmacol. 1999;55:521\u2013525. doi: 10.1007/s002280050667.", "ArticleIdList": ["10.1007/s002280050667", "10501822"]}, {"Citation": "Rawat M., Jain A., Mishra A., Muthu M., Singh S. Development of repaglinide loaded solid lipid nanocarrier: Selection of fabrication method. Curr. Drug Deliv. 2010;7:44\u201350. doi: 10.2174/156720110790396472.", "ArticleIdList": ["10.2174/156720110790396472", "20044909"]}, {"Citation": "Derosa G., Mugellini A., Ciccarelli L., Crescenzi G., Fogari R. Comparison of glycaemic control and cardiovascular risk profile in patients with type 2 diabetes during treatment with either repaglinide or metformin. Diabetes Res. Clin. Pract. 2003;60:161\u2013169. doi: 10.1016/S0168-8227(03)00057-3.", "ArticleIdList": ["10.1016/S0168-8227(03)00057-3", "12757988"]}, {"Citation": "Poovi G., Kishore N., Reddy P.N. In vitro characterization and in vivo toxicity study of repaglinide loaded poly (methyl methacrylate) nanoparticles. Int. J. Pharm. 2010;396:194\u2013203.", "ArticleIdList": ["20600729"]}, {"Citation": "Auro Pharma Inc.  PrAURO-REPAGLINIDE. 2016.  [(accessed on 1 January 2020)].  Available online:  https://pdf.hres.ca/dpd_pm/00034683.PDF."}, {"Citation": "Foroumadi R., Baeeri M., Asgarian S., Emamgholipour Z., Goli F., Firoozpour L., Keykhaei M., Gholami M., Dehpour A.R., Abdollahi M. Antidiabetic and neuroprotective effects of a novel repaglinide analog. J. Biochem. Mol. Toxicol. 2022;36:e23125. doi: 10.1002/jbt.23125.", "ArticleIdList": ["10.1002/jbt.23125", "35702883"]}, {"Citation": "Hatorp V. Clinical pharmacokinetics and pharmacodynamics of repaglinide. Clin. Pharmacokinet. 2002;41:471\u2013483. doi: 10.2165/00003088-200241070-00002.", "ArticleIdList": ["10.2165/00003088-200241070-00002", "12083976"]}, {"Citation": "Kara\u017aniewicz-\u0141ada M., B\u0105ba K., Dolatowski F., Dobrowolska A., Rakicka M. The polymorphism of statins and its effect on their physicochemical properties. Polim Med. 2018;48:77\u201382. doi: 10.17219/pim/102978.", "ArticleIdList": ["10.17219/pim/102978", "30916495"]}, {"Citation": "Yasir M., Asif M., Kumar A., Aggarval A. Biopharmaceutical classification system: An account. Int. J. PharmTech Res. 2010;2:1681\u20131690."}, {"Citation": "Amidon G.L., Lennern\u00e4s H., Shah V.P., Crison J.R. A theoretical basis for a biopharmaceutic drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res. 1995;12:413\u2013420. doi: 10.1023/A:1016212804288.", "ArticleIdList": ["10.1023/A:1016212804288", "7617530"]}, {"Citation": "Wu C.-Y., Benet L.Z. Predicting drug disposition via application of BCS: Transport/absorption/elimination interplay and development of a biopharmaceutics drug disposition classification system. Pharm. Res. 2005;22:11\u201323. doi: 10.1007/s11095-004-9004-4.", "ArticleIdList": ["10.1007/s11095-004-9004-4", "15771225"]}, {"Citation": "L\u00f6benberg R., Amidon G.L. Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards. Eur. J. Pharm. Biopharm. 2000;50:3\u201312. doi: 10.1016/S0939-6411(00)00091-6.", "ArticleIdList": ["10.1016/S0939-6411(00)00091-6", "10840189"]}, {"Citation": "Mansouri M., Pouretedal H.R., Vosoughi V. Preparation and characterization of ibuprofen nanoparticles by using solvent/antisolvent precipitation. Open Conf. Proc. J. 2011;2:88\u201394. doi: 10.2174/2210289201102010088.", "ArticleIdList": ["10.2174/2210289201102010088"]}, {"Citation": "Sachan N.K., Bhattacharya A., Pushkar S., Mishra A. Biopharmaceutical classification system: A strategic tool for oral drug delivery technology. Asian J. Pharm. 2009;3:76. doi: 10.4103/0973-8398.55042.", "ArticleIdList": ["10.4103/0973-8398.55042"]}, {"Citation": "Lonare A.A., Patel S.R. Antisolvent crystallization of poorly water soluble drugs. Int. J. Chem. Eng. Appl. 2013;4:337. doi: 10.7763/IJCEA.2013.V4.321.", "ArticleIdList": ["10.7763/IJCEA.2013.V4.321"]}, {"Citation": "Surendiran A., Sandhiya S., Pradhan S., Adithan C. Novel applications of nanotechnology in medicine. Indian J. Med. Res. 2009;130:689\u2013701.", "ArticleIdList": ["20090129"]}, {"Citation": "Demello A.J. Control and detection of chemical reactions in microfluidic systems. Nature. 2006;442:394\u2013402. doi: 10.1038/nature05062.", "ArticleIdList": ["10.1038/nature05062", "16871207"]}, {"Citation": "Zhang Y., Chan H.F., Leong K.W. Advanced materials and processing for drug delivery: The past and the future. Adv. Drug Deliv. Rev. 2013;65:104\u2013120. doi: 10.1016/j.addr.2012.10.003.", "ArticleIdList": ["10.1016/j.addr.2012.10.003", "PMC3565095", "23088863"]}, {"Citation": "Plakkot S., De Matas M., York P., Saunders M., Sulaiman B. Comminution of ibuprofen to produce nano-particles for rapid dissolution. Int. J. Pharm. 2011;415:307\u2013314. doi: 10.1016/j.ijpharm.2011.06.002.", "ArticleIdList": ["10.1016/j.ijpharm.2011.06.002", "21683776"]}, {"Citation": "Van Eerdenbrugh B., Vermant J., Martens J.A., Froyen L., Humbeeck J.V., Van den Mooter G., Augustijns P. Solubility increases associated with crystalline drug nanoparticles: Methodologies and significance. Mol. Pharm. 2010;7:1858\u20131870. doi: 10.1021/mp100209b.", "ArticleIdList": ["10.1021/mp100209b", "20822111"]}, {"Citation": "Liu G., Xun S., Vukmirovic N., Song X., Olalde-Velasco P., Zheng H., Battaglia V.S., Wang L., Yang W. Polymers with tailored electronic structure for high capacity lithium battery electrodes. Adv. Mater. 2011;23:4679\u20134683. doi: 10.1002/adma.201102421.", "ArticleIdList": ["10.1002/adma.201102421", "21953600"]}, {"Citation": "Thakkar H.P., Patel B.V., Thakkar S.P. Development and characterization of nanosuspensions of olmesartan medoxomil for bioavailability enhancement. J. Pharm. Bioallied Sci. 2011;3:426. doi: 10.4103/0975-7406.84459.", "ArticleIdList": ["10.4103/0975-7406.84459", "PMC3178951", "21966165"]}, {"Citation": "Khan S., Matas M.D., Zhang J., Anwar J. Nanocrystal preparation: Low-energy precipitation method revisited. Cryst. Growth Des. 2013;13:2766\u20132777. doi: 10.1021/cg4000473.", "ArticleIdList": ["10.1021/cg4000473"]}, {"Citation": "Shekunov B.Y., Chattopadhyay P., Seitzinger J., Huff R. Nanoparticles of poorly water-soluble drugs prepared by supercritical fluid extraction of emulsions. Pharm. Res. 2006;23:196\u2013204. doi: 10.1007/s11095-005-8635-4.", "ArticleIdList": ["10.1007/s11095-005-8635-4", "16307386"]}, {"Citation": "Lorke D. A new approach to practical acute toxicity testing. Arch. Toxicol. 1983;54:275\u2013287. doi: 10.1007/BF01234480.", "ArticleIdList": ["10.1007/BF01234480", "6667118"]}, {"Citation": "Oguntibeju O.O., Meyer S., Aboua Y.G., Goboza M. Hypoxis hemerocallidea Significantly Reduced Hyperglycaemia and Hyperglycaemic-Induced Oxidative Stress in the Liver and Kidney Tissues of Streptozotocin-Induced Diabetic Male Wistar Rats. Evid.-Based Complement. Altern. Med. 2016;2016:8934362. doi: 10.1155/2016/8934362.", "ArticleIdList": ["10.1155/2016/8934362", "PMC4925985", "27403200"]}, {"Citation": "Kumar V., Bhatt P.C., Kaithwas G., Rashid M., Al-abbasi F., Khan J.A., Anwar F., Verma A. \u03b1-Mangostin Mediated Pharmacological Modulation of Hepatic Carbohydrate Metabolism in Diabetes Induced Wistar Rat. Beni-Suef Univ. J. Basic Appl. Sci. 2016;5:255\u2013276. doi: 10.1016/j.bjbas.2016.07.001.", "ArticleIdList": ["10.1016/j.bjbas.2016.07.001"]}, {"Citation": "Do\u011fan A., \u00c7elik \u0130. Healing effects of sumac (Rhus coriaria) in streptozotocin-induced diabetic rats. Pharm. Biol. 2016;54:2092\u20132102. doi: 10.3109/13880209.2016.1145702.", "ArticleIdList": ["10.3109/13880209.2016.1145702", "26957014"]}, {"Citation": "Weibel D.B., Whitesides G.M. Applications of microfluidics in chemical biology. Curr. Opin. Chem. Biol. 2006;10:584\u2013591. doi: 10.1016/j.cbpa.2006.10.016.", "ArticleIdList": ["10.1016/j.cbpa.2006.10.016", "17056296"]}, {"Citation": "Ali H.S., York P., Blagden N. Preparation of hydrocortisone nanosuspension through a bottom-up nanoprecipitation technique using microfluidic reactors. Int. J. Pharm. 2009;375:107\u2013113. doi: 10.1016/j.ijpharm.2009.03.029.", "ArticleIdList": ["10.1016/j.ijpharm.2009.03.029", "19481696"]}, {"Citation": "Matteucci M.E., Hotze M.A., Johnston K.P., Williams R.O. Drug nanoparticles by antisolvent precipitation: Mixing energy versus surfactant stabilization. Langmuir. 2006;22:8951\u20138959. doi: 10.1021/la061122t.", "ArticleIdList": ["10.1021/la061122t", "17014140"]}, {"Citation": "Xia D., Quan P., Piao H., Piao H., Sun S., Yin Y., Cui F. Preparation of stable nitrendipine nanosuspensions using the precipitation\u2013ultrasonication method for enhancement of dissolution and oral bioavailability. Eur. J. Pharm. Sci. 2010;40:325\u2013334. doi: 10.1016/j.ejps.2010.04.006.", "ArticleIdList": ["10.1016/j.ejps.2010.04.006", "20417274"]}, {"Citation": "Deng J., Huang L., Liu F. Understanding the structure and stability of paclitaxel nanocrystals. Int. J. Pharm. 2010;390:242\u2013249. doi: 10.1016/j.ijpharm.2010.02.013.", "ArticleIdList": ["10.1016/j.ijpharm.2010.02.013", "PMC3685190", "20167270"]}, {"Citation": "Yang J.Z., Young A.L., Chiang P.C., Thurston A., Pretzer D.K. Fluticasone and budesonide nanosuspensions for pulmonary delivery: Preparation, characterization, and pharmacokinetic studies. J. Pharm. Sci. 2008;97:4869\u20134878. doi: 10.1002/jps.21380.", "ArticleIdList": ["10.1002/jps.21380", "18351635"]}, {"Citation": "Jacobs C., M\u00fcller R.H. Production and characterization of a budesonide nanosuspension for pulmonary administration. Pharm. Res. 2002;19:189\u2013194. doi: 10.1023/A:1014276917363.", "ArticleIdList": ["10.1023/A:1014276917363", "11883646"]}, {"Citation": "Wu L., Zhang J., Watanabe W. Physical and chemical stability of drug nanoparticles. Adv. Drug Del. Rev. 2011;63:456\u2013469. doi: 10.1016/j.addr.2011.02.001.", "ArticleIdList": ["10.1016/j.addr.2011.02.001", "21315781"]}, {"Citation": "Freitas C., M\u00fcller R.H. Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLN\u2122) dispersions. Int. J. Pharm. 1998;168:221\u2013229. doi: 10.1016/S0378-5173(98)00092-1.", "ArticleIdList": ["10.1016/S0378-5173(98)00092-1"]}, {"Citation": "Bunjes H., Koch M.H., Westesen K. Effect of particle size on colloidal solid triglycerides. Langmuir. 2000;16:5234\u20135241. doi: 10.1021/la990856l.", "ArticleIdList": ["10.1021/la990856l"]}, {"Citation": "Valleri M., Mura P., Maestrelli F., Cirri M., Ballerini R. Development and evaluation of glyburide fast dissolving tablets using solid dispersion technique. Drug Dev. Ind. Pharm. 2004;30:525\u2013534. doi: 10.1081/DDC-120037483.", "ArticleIdList": ["10.1081/DDC-120037483", "15244088"]}, {"Citation": "O\u2019Mahony M., Leung A.K., Ferguson S., Trout B.L., Myerson A.S. A Process for the Formation of Nanocrystals of Active Pharmaceutical Ingredients with Poor Aqueous Solubility in a Nanoporous Substrate. Org. Process Res. Dev. 2014;19:1109\u20131118. doi: 10.1021/op500262q.", "ArticleIdList": ["10.1021/op500262q"]}, {"Citation": "Ali H.S., York P., Ali A.M., Blagden N. Hydrocortisone nanosuspensions for ophthalmic delivery: A comparative study between microfluidic nanoprecipitation and wet milling. J. Control. Release. 2011;149:175\u2013181. doi: 10.1016/j.jconrel.2010.10.007.", "ArticleIdList": ["10.1016/j.jconrel.2010.10.007", "20946923"]}, {"Citation": "M\u00fcller R.H., Peters K. Nanosuspensions for the formulation of poorly soluble drugs: I. Preparation by a size-reduction technique. Int. J. Pharm. 1998;160:229\u2013237. doi: 10.1016/S0378-5173(97)00311-6.", "ArticleIdList": ["10.1016/S0378-5173(97)00311-6"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "3", "Day": "1"}, {"Year": "2023", "Month": "3", "Day": "28"}, {"Year": "2023", "Month": "3", "Day": "28"}, {"Year": "2023", "Month": "5", "Day": "16", "Hour": "6", "Minute": "43"}, {"Year": "2023", "Month": "5", "Day": "16", "Hour": "6", "Minute": "42"}, {"Year": "2023", "Month": "5", "Day": "16", "Hour": "1", "Minute": "10"}, {"Year": "2023", "Month": "4", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["37189682", "PMC10135525", "10.3390/biomedicines11041064", "biomedicines11041064"]}}], "PubmedBookArticle": []}